2006, Number 6
<< Back Next >>
Gac Med Mex 2006; 142 (6)
Crusted scabies (Norweian scabies). A case report.
Fernández-Tamayo N, Flores-Villa R, Blanco-Aguilar J, Dueñas-Arau MA, Peña-Flores MPC, Rubio-Calva C, Santos-Marcial E
Language: Spanish
References: 20
Page: 507-510
PDF size: 464.55 Kb.
ABSTRACT
Different types of scabies have been described based on their clinical outcome, one of which is the Crusted (Norwegian) type. This is an extreme manifestation of scabies that can be observed mainly among immunosupressed patients.
A case of a 42 year-old homosexual man is described . The patient was diagnosed with HIV, presenting pruritic lesions with a 4 month evolution in trunk and extremities. Lesions included xerosis, decapitated papules, badges with erythema, residual hyperchromic stains, multiple abrasions and ungueal pigmentation in both feet. At the beginning it was treated as a psorasiform dermatitis with steroids and antipruritics without success. Through a biopsy the suspected diagnosis of Crusted (Norwegian) scabies was confirmed. The patient was treated with a dose of oral ivermectin and topical benzyl benzoate and showed remission after two days.
REFERENCES
Karthikeyan K. Treatment of Scabies: newer perspectives. Postgrad. Med.J 2005;81:7-11.
Aubin F, Humbert P. Ivermectin for crusted scabies [letter]. N. Engl J Med 1995;332:612.
Fajardo-Velázquez R, Urdez-Hernández E, Ysita-Morales A. Nosocomial outbreak of scabies from a Norwegian scabies case. Salud Publica Mex 2004;46:251-254.
Castano-Molina C, Cockerell CJ. Diagnosis and Treatment of infectious diseases in HIV-infected hosts. Dermatol Clin 1997;15:267-283.
Walton SF, McBroom J, Mathews JD, Kemp DJ, Currie BJ. Crusted scabies: a molecular analysis of Sarcoptes scabiei variety hominis population from patients with repeated infestations, Clinical Infectious Diseases 1999;29:1226-1239.
Wright RA, Judson FN. Relative and seasonal incidences of the sexually transmitted diseases. A two-year statistical review. Br J. Vener Dis 1978;54:433-440.
Kristensen JK. Scabies and pyoderma in Lilongwe, Malawi. Prevalence and seasonal fluctuation. Int J Dermatol 1991;30:699-702.
Otero L, Varela JA, Espinosa E, Sánchez C, Junquera ML, Del Valle A, et al. Sarcoptes scabiei in a sexually transmitted infections unit, a 15 years study. Sexually transmitted diseases 2004;31:761-764.
Rueda-Zambrano FA, Cáceres-Corredor P. Manejo práctico de la escabiosis en niños. MEDUNAB 2002;5:112-117.
Chouvet B, Ortonne JP, Perrot H, Thivolet J. La gale norvégienne: circonstances étiologiques. Ann Dermatol Verereol 1979;106:569-574.
Cestari SCP, Petri V, Rotta O, Alchorne MMA. Oral treatment of crusted scabies with Ivermectin: Report of two cases. Pediatric Dermatology 2000;17:410-414.
Fonseca ME, Annete A, Arteaga E, Rodríguez E. Importancia de la atención de enfermería en la Sarna Noruega. Rev Cubana Enfermer 2001;17:152-157.
Bezold G, Lange M, Schiener R, Palmedo G, Sander CA, Kerscher M, et al. Hiden scabies: diagnosis by polymerase chain reaction. 2001, British Association of dermatologist, pp. 614-618.
Gach JE, Heagerty A. Crusted scabies looking like psoriasis. The Lancet 2000;356:620.
Samson SY, Wong-Patrick CY, Woo, Kwok-Yung Yuen. Unsual laboratory finding in a case of norweian scabies provided a clue to diagnosis. Journal of Clinical Microbiology.2005;43:2542-2544.
Meinking TL, Taplin D, Hermida JL. The treatment of scabies with ivermectin. N Engl J Med 2001;333:26-30.
La Fuente CR. Is it scabies? How to tell. The Nurse Practitioner 2003;28:57-59.
Currie BJ, Harumal P, McKinnon M, Walton SF. First documentation of in vivo and in vitro ivermectin resistance in sarcoptes scabiei. Clin Infect Dis 2004.39:8-12.
Alberici L, Pagani G, Ratti P. Viale ivermectin alone of in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies. British Journal of Dermatology 2000;142:969-972.
Walton SF, McBroom J, Mathews JD, Kemp DJ, Currie BJ. Crusted scabies: a molecular analysis of sarcoptes scabiei variety hominis population from patients with repeated infestations. Clin Infec Dis 1999;29:1226-1239.